Member News
-
Valeo Pharma Enters into License Agreement with Kaléo for the Canadian Rights to ALLERJECT®
700,000 Canadians suffering from severe allergies Canadian epinephrine auto-injector market exceeds $80M annually ALLERJECT peak sales potential expected to…
-
Valeo Pharma Enters into an Agreement for Ophthalmic Products, PrXIIDRA® AND PrSIMBRINZA®, in Canada
Ophthalmology becomes additional strategic therapeutic area Significant market opportunities with more than 6 million1 Canadians suffering from dry eye…
-
Valeo Pharma Reports Its Second Quarter 2022 Results and Highlights
Q2-22 revenues of $4.8 million, up 80% over Q2-21 Q2-22 gross margins of $1.7 million, up 134% over Q2-21 Canadian…
-
Valeo Pharma to Host Second Quarter 2022 Results Conference Call / Webcast
June 8, 2022 (Source) — Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Valeo Pharma Announces Results of Annual Meeting of Shareholders, Appointments and Options and RSU Grants
April 28, 2022 (Source) – Valeo Pharma Inc. (TSX:VPH) (OTCQB: VPHIF) (FSE:VP2) (“Valeo” or the “Company”), a Canadian…
-
Valeo Pharma to Present at the 2022 Bloom Burton & Co Healthcare Investor Conference
April 25, 2022 (Source) – Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Valeo Pharma Announces Listing of Convertible Debentures on TSX
April 19, 2022 (Source) – Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”), a…
-
Valeo Pharma Announces Listing to the Toronto Stock Exchange
The Company’s shares and warrants to start trading on March 29th, 2022 March 28, 2022 (Source) — Valeo Pharma Inc.…
-
Valeo Pharma Reports Its First Quarter 2022 Results and Highlights
Q1-22 revenues of $4.2 million, up 128% over Q1-21 Q1-22 gross margins of $1.4 million, up 266% over Q1-21 Public…
-
Valeo Pharma Secures Additional Public Reimbursement for Redesca™, Enerzair® Breezhaler® and Atectura® Breezhaler®
Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia Enerzair Breezhaler and Atectura Breezhaler…
